Performance-Enhancing Drugs in Sport

Endocrinology and Metabolism Clinics of North America

Volumn 36, Issue 2, 2007, Pages 481-495

  Carpenter, Paul C ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 HYDROXYBUTYRIC ACID; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; ANABOLIC AGENT; ANDROSTENEDIONE; BOLDENONE; BUFOTENINE; CANNABIS; CENTRAL STIMULANT AGENT; CLOMIFENE CITRATE; COCAINE; CREATINE; EPHEDRINE; ERYTHROPOIETIN; GROWTH HORMONE; INSULIN; NANDROLONE; NEUROTRANSMITTER; NON PRESCRIPTION DRUG; OXANDROLONE; PRASTERONE; PSYCHEDELIC AGENT; RECOMBINANT ERYTHROPOIETIN; SESAME SEED OIL; STANOZOLOL; TAMOXIFEN; TESTOSTERONE ENANTATE;

ACNE; ACT; ADENOMATOSIS; AMENORRHEA; ASIA; ATHLETE; ATTITUDE TO HEALTH; BREAST ATROPHY; CARDIOMYOPATHY; CHOLESTEROL BLOOD LEVEL; CLITORIS HYPERTROPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIET SUPPLEMENTATION; DOPING; DRUG ABUSE; DRUG DETERMINATION; DRUG USE; EDEMA; EUROPE; FEMALE INFERTILITY; FOOD AND DRUG ADMINISTRATION; GROWTH RETARDATION; HEALTH HAZARD; HEALTH PROGRAM; HIRSUTISM; HUMAN; HYPERTENSION; HYPERTROPHY; JAUNDICE; LIFESTYLE; MAJOR DEPRESSION; NUTRITIONAL STATUS; PELIOSIS HEPATIS; PERFORMANCE; PHYSIOLOGY; POLYCYTHEMIA; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RESPONSIBILITY; REVIEW; SIDE EFFECT; SOCIAL ENVIRONMENT; SPORT; SPORTS MEDICINE; STRENGTH; THROMBOSIS; TREMOR; UNITED STATES; VOICE CHANGE;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT PSYCHOLOGY; ANABOLIC AGENTS; DOPING IN SPORTS; FORECASTING; HUMANS; STEROIDS; SUBSTANCE-RELATED DISORDERS;

EID: 34249299075     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2007.03.006     Document Type: Review

References (70)

1. Labre M.P. Adolescent boys and the muscular male body ideal. J Adolesc Health 30 (2002) 233-242
2. Kanayama G., Barry S., Hudson J.I., et al. Body image and attitudes toward male roles in anabolic-androgenic steroid users. Am J Psychiatry 163 4 (2006) 697-703
3. Faigenbaum A.D., Zaichkowsky L.D., Gardner D.E., et al. Anabolic steroids used by male and female middle school students. Pediatrics 101 (1998) 916-917
4. Field A.E., Austin S.B., Camargo Jr. C.A., et al. Exposure to the mass media, body shape concerns, and use of supplements to improve weight and shape among male and female adolescents. Pediatrics 116 2 (2005) e214-e220
5. Radakovich J., Broderick P., and Pickell G. Rate of anabolic-androgenic steroid use among students in junior high school. J Am Board Fam Pract 6 4 (1993) 341-345
6. Tanner S.M., Miller D.W., and Alongi C. Anabolic steroid use by adolescents: prevalence, motives, and knowledge of risks. Clin J Sport Med 5 2 (1995) 108-115
7. Anonymous. Adolescents and anabolic steroids: a subject review. Am Acad Pediatrics. Committee on Sports Medicine and Fitness. Pediatrics 99 6 (1997) 904-908
8. Metzl J.D. Performance-enhancing drug use in the young athlete. Pediatr Ann 31 1 (2002) 27-32
9. Irving L.M., Wall M., Neumark-Sztainer D., et al. Steroid use among adolescents: findings from Project EAT. J Adolesc Health 30 (2002) 243-252
10. Gomez J.E. Performance-enhancing substances in adolescent athletes. Tex Med 98 (2002) 41-46
11. Laure P., Lecerf T., Friser A., et al. Drugs, recreational drug use and attitudes towards doping of high school athletes. Int J Sports Med 25 2 (2004) 133-138
12. Metzl J.D. Anabolic steroids and the pediatric community. Pediatrics 116 6 (2005) 1542
13. Naylor A.H., Gardner D., and Zaichkowsky L. Drug use patterns among high school athletes and nonathletes. Adolescence 36 144 (2001) 627-639
14. Metzl J.D. Sports medicine in pediatric practice: keeping pace with the changing times. Pediatr Ann 29 (2000) 146-148
15. Stilger V.G., and Yesalis C.E. Anabolic-androgenic steroid use among high school football players. J Community Health 24 2 (1999) 131-145
16. Whitehead R., Chillag S., and Elliott D. Anabolic steroid use among adolescents in a rural state. J Fam Pract 35 4 (1992) 401-405
17. Scott D.M., Wagner J.C., and Barlow T.W. Anabolic steroid use among adolescents in Nebraska schools. Am J Health Syst Pharm 53 17 (1996) 2068-2072
18. National Household Survey on Drug Abuse. United States Department of health and human services. Available at: http://www.samhsa.gov/oas/nhsda.htm#NHSDAinfo.
19. Green G.A., Uryasz F.D., Petr T.A., et al. NCAA study of substance use and abuse habits of college student-athletes. Clin J Sport Med 11 1 (2001) 51-56
20. Johnston LD, O'Malley PM, Bachman JG. Demographic subgroup trends for various licit and illicit drugs, 1975-2001. Monitoring the future-occasional paper No. 57. Ann Arbor (MI): Institute for Social Research; 2002.
21. Calfee R., and Fadale P. Popular ergogenic drugs and supplements in young athletes. Pediatrics 117 3 (2006) e577-e589
22. Moore M.J., and Werch C.E. Sport and physical activity participation and substance use among adolescents. J Adolesc Health 36 6 (2005) 486-493
23. Golberg L., Elliot D., MacKinnon D., et al. Drug testing athletes to prevent substance abuse: background and pilot study results of the SATURN (Student Athlete Testing Using Random Notification) study. J Adolesc Health 32 (2003) 16-25
24. Elliot D.L., Goldberg L., Moe E.L., et al. Preventing substance use and disordered eating: initial outcomes of the ATHENA (athletes targeting healthy exercise and nutrition alternatives) program. Arch Pediatr Adolesc Med 158 11 (2004) 1043-1049
25. Elliot D., and Goldberg L. Intervention and prevention of steroid use in adolescents. Am J Sports Med 24 6 Suppl (1996) S46-S47
26. Goldberg L., MacKinnon D.P., Elliot D.L., et al. The adolescents training and learning to avoid steroids program: preventing drug use and promoting health behaviors. Arch Pediatr Adolesc Med 154 4 (2000) 332-338
27. Fritz M.S., MacKinnon D.P., Williams J., et al. Analysis of baseline by treatment interactions in a drug prevention and health promotion program for high school male athletes. Addict Behav 30 5 (2005) 1001-1005
28. Gomez J.E. American Academy of Pediatrics Committee on Sports Medicine and Fitness. Use of performance-enhancing substances. Pediatrics 115 4 (2005) 1103-1106
29. Estrin I., and Sher L. The constitutionality of random drug and alcohol testing in secondary schools. Int J Adolesc Med Health 18 1 (2006) 21-25
30. Pope H.G., Kanayama G., Ionescu-Pioggia M., et al. Anabolic steroid users' attitudes towards physicians. Addiction 99 9 (2004) 1189-1194
31. Anshel M.H., and Russell K.G. Examining athletes' attitudes toward using anabolic steroids and their knowledge of the possible effects. J Drug Educ 27 2 (1997) 121-145
32. Porcerelli J.H., and Sandler B.A. Narcissism and empathy in steroid users. Am J Psychiatry 152 11 (1995) 1672-1674
33. Tokish J.M., Kocher M.S., and Hawkins R.J. Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med 32 (2004) 1543-1553
34. Blue J.G., and Lombardo J.A. Steroids and steroid-like compounds. Clin Sports Med 18 3 (1999) 667-689
35. Bemben M.G., and Lamont H.S. Creatine supplementation and exercise performance: recent findings. Sports Med 35 2 (2005) 107-125
36. Kouri E.M., Pope Jr. H.G., Katz D.L., et al. Fat-free mass index in users and nonusers of anabolic-androgenic steroids. Clin J Sport Med 5 4 (1995) 223-228
37. Ninot G., Connes P., and Caillaud C. Effects of recombinant human erythropoietin injections on physical self in endurance athletes. J Sports Sci 24 4 (2006) 383-391
38. Pope Jr. H.G., and Katz D.L. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 51 5 (1994) 375-382
39. Healy M.L., Gibney J., Russell-Jones D.L., et al. High dose growth hormone exerts an anabolic effect at rest and during exercise in endurance-trained athletes. J Clin Endocrinol Metab 88 11 (2003) 5221-5226
40. Seehusen D.A., and Glorioso J.E. Tamoxifen as an ergogenic agent in women body builders. Clin J Sport Med 12 5 (2002) 313-314
41. Stacy J.J., Terrell T.R., and Armsey T.D. Ergogenic aids: human growth hormone. Curr Sports Med Rep 3 4 (2004) 229-233
42. Bryden A.A., Rothwell P.J., and O'Reilly P.H. Anabolic steroid abuse and renal-cell carcinoma. Lancet 346 8985 (1995) 1306-1307
43. Kanayama G., Pope H.G., Cohane G., et al. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Drug Alcohol Depend 71 1 (2003) 77-86
44. Parssinen M., Kujala U., Vartiainen E., et al. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 21 3 (2000) 225-227
45. Cooper C.J., Noakes T.D., Dunne T., et al. A high prevalence of abnormal personality traits in chronic users of anabolic-androgenic steroids. Br J Sports Med 30 3 (1996) 246-250
46. Midgley S.J., Heather N., and Davies J.B. Levels of aggression among a group of anabolic-androgenic steroid users. Med Sci Law 41 4 (2001) 309-314
47. Dickerman R.D., McConathy W.J., and Zachariah N.Y. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk. J Cardiovasc Risk 4 5-6 (1997) 363-366
48. Bahrke M.S., Yesalis C.E., Kopstein A.N., et al. Risk factors associated with anabolic steroids use among adolescents. Sports Med 29 (2000) 397-406
49. Kennedy M.C., and Lawrence C. Anabolic steroid abuse and cardiac death. Med J Aust 158 5 (1993) 346-348
50. Bizzarini E., and De Angelis L. Is the use of oral creatine supplementation safe?. J Sports Med Phys Fitness 44 4 (2004) 411-416
51. Karila T., Hovatta O., and Seppala T. Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes. Int J Sports Med 25 4 (2004) 257-263
52. Evans P.J., and Lynch R.M. Insulin as a drug of abuse in body building. Br J Sports Med 37 4 (2003) 356-357
53. Okudan N., and Gokbel H. The effects of creatine supplementation on performance during the repeated bouts of supramaximal exercise. J Sports Med Phys Fitness 45 4 (2005) 507-511
54. Karila T., Koistinen H., Seppala M., et al. Growth hormone induced increase in serum IGFBP-3 level is reversed by anabolic steroids in substance abusing power athletes. Clin Endocrinol (Oxf) 49 4 (1998) 459-463
55. Konrad C., Schupfer G., Wietlisbach M., et al. Insulin as an anabolic: hypoglycemia in the bodybuilding world. Anasthesiol Intensivmed Notfallmed Schmerzther 33 7 (1998) 461-463 [in German]
56. Healy M.L., and Russell-Jones D. Growth hormone and sport: abuse, potential benefits, and difficulties in detection. Br J Sports Med 31 4 (1997) 267-268
57. Handelsman D.J. Clinical review: the rationale for banning human chorionic gonadotropin and estrogen blockers in sport. J Clin Endocrinol Metab 91 5 (2006) 1646-1653
58. Pearce P.Z. Sports supplements: a modern case of caveat emptor. Curr Sports Med Rep 4 3 (2005) 171-178
59. Orchard J.W., Fricker P.A., White S.L., et al. The use and misuse of performance-enhancing substances in sport. Med J Aust 184 3 (2006) 132-136
60. Sekera M.H., Ahrens B.D., Chang Y.C., et al. Another designer steroid: discovery. Synthesis and detection of 'madol' in urine. Rapid Commun Mass Spectrom 19 6 (2005) 781-784
61. Handelsman D.J. Designer androgens in sport: when too much is never enough. Sci STKE 27 (2004) e41
62. Barton-Davis E.R., Shoturma D.I., Musaro A., et al. Viral mediated expression of IGF-I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci U S A 95 (1998) 15603-15607
63. Wang X.Y., Zhang C.-L., Yu R.T., et al. Regulation of muscle fiber type and running endurance by PPARδ. PLoS Biol 2 10 (2004) e294
64. Dressel U., Allen T.L., Pippal J.B., et al. The peroxisome proliferator-activated receptor ß/δ agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 17 12 (2004) 2477-2493
65. Rigamonti A.E., Cella S.G., Marazzi N., et al. Growth hormone abuse: methods of detection. Trends Endocrinol Metab 16 4 (2005) 160-166
66. Thevis M., Thomas A., Delahaut P., et al. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry. Anal Chem 78 6 (2006) 1897-1903
67. Maughan R.J. Contamination of dietary supplements and positive drug tests in sport. J Sports Sci 23 9 (2005) 883-889
68. Thevis M., Geyer H., Mareck U., et al. Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. J Mass Spectrom 40 7 (2005) 955-962
69. Goebel C., Alma C., Howe C., et al. Methodologies for detection of hemoglobin-based oxygen carriers. J Chromatogr Sci 43 1 (2005) 39-46
70. Healy M.L., Dall R., Gibney J., et al. Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the post-competition setting. J Clin Endocrinol Metab 90 2 (2005) 641-649